Headlines

European Pre-Market Summary 10th November 2026: Earnings remain in focus, Ferrexpo stops production

Newsquawk Staff ·

Q3 Earnings

  • Henkel (HEN3 GY): Revenue in-line. FY26 Organic Sales guidance midpoint beat.
  • K+S (SDF GY): adj. EBITDA & Revenue beat. Narrows FY26 EBITDA guidance, due to supply-side constraints.

Q4 Earnings

  • Infineon (IFX GY): Revenue in-line, adj. EPS & Gross Margin higher Y/Y. Q1 Revenue guide miss. FY27 Revenue guide beat. Dividend increase. CEO: "expect a significant increase in revenue and profitability in fiscal year 2027"

H1 Earnings

  • Vodafone (VOD LN): Revenue beat, adj. EBITDAaL Organic Growth higher Y/Y. Upgrades FY27 adj. EBITDAaL and adj. FCF guidance.

Pharmaceutical

  • Roche (ROP SW): Updated Phase Ib/IIa Brainshuttle™ AD study data for trontinemab demonstrating rapid amyloid removal dynamics and changes in key biomarkers.
  • Bayer (BAYN GY): FDA has approved SUNHARBO (asundexian), 50 mg tablets, a first-in-class, once daily, Factor XIa inhibitor indicated in combination with antiplatelet therapy to reduce the risk of stroke in adults with NIHSS or TIA.

Reports/Updates

  • BT (BT/A LN): Co. will not launch its partnership with SpaceX's (SPCX) Starlink, following on from the controversy surrounding signal failures in Ukraine, FT reports.
  • Ferrexpo (FXPO LN): Following Ukrainian electricity damage, it has been decided to temporarily stop production.

Related headlines